Despite decades of efforts to find neuroprotective agents against cerebral ischemia, for example, genetic approaches have recently been proposed for stroke treatment, using viral vectors carrying transcription factors such as Sox2, Ngn2, or Ascl1 to isolate astrocytes which direct reprogramming into neurons [27], but further research is needed. This evidence concerns the gene NEUROG2 and stroke disorder.